Independent anti-corruption organisation Transparency International (TI) said on Tuesday that there are large discrepancies in the prices paid for Covid-19 vaccines, revealing that upper-middle income countries like South Africa paid an average of 25% more per dose for the Oxford/AstraZeneca vaccine, compared with high income economies, such as the US and the European Union.
South Africa halted the use of the Oxford/AstraZeneca vaccine, developed by the Serum Institute of India (SII), in February after its efficacy to treat the SARS-CoV-2 variant of the Covid-19 virus was called into question.
Advertisement
South Africa sold its Oxford/AstraZeneca doses to the African Union and was refunded by the SII for other doses that were ordered but not yet delivered.
SA paid 25% more for Oxford/AstraZeneca vaccine than high-income economies – Study
polity.org.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from polity.org.za Daily Mail and Mail on Sunday newspapers.
Verfahren: Hofpfisterei beansprucht „Sonne im Brot für sich - Bayern - Nachrichten
mittelbayerische.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mittelbayerische.de Daily Mail and Mail on Sunday newspapers.